Should Avastin be used to treat age-related macular degeneration in the NHS?--Yes. by Raftery, J, Dent, L

Health Technology Assessment in the UK. by Raftery, J, Powell, J

Research impact: a narrative review. by Greenhalgh, T, Raftery, J, Hanney, S, Glover, M

Research impact: a narrative review by Greenhalgh, T, Raftery, J, Hanney, S, Glover, M

Research impact: A narrative review by Greenhalgh, P, Raftery, J, Hanney, S, Glover, M

Payment to healthcare professionals for patient recruitment to trials: systematic review and qualitative study. by Raftery, J, Bryant, J, Powell, J, Kerr, C, Hawker, S

Models and applications for measuring the impact of health research: update of a systematic review for the Health Technology Assessment programme. by Raftery, J, Hanley, S, Greenhalgh, T, Glover, M, Blotch-Jones, A

The impact on healthcare, policy and practice from 36 multi-project research programmes: findings from two reviews. by Hanney, S, Greenhalgh, T, Blatch-Jones, A, Glover, M, Raftery, J

A controlled trial of home-based acute psychiatric services. II: Treatment patterns and costs. by Burns, T, Raftery, J, Beadsmoore, A, McGuigan, S, Dickson, M

THE BEAUTY OF MAPPING: NEED THE MEAN HEALTH-RELATED QUALITY OF LIFE SCORE FOR A GROUP OF HIP PATIENTS AND DON'T HAVE EQ-5D? JUST USE THE OXFORD HIP SCORE! by Villanueva, P, Turner, D, Judge, A, Raftery, J, Arden, N

Stereoselective, nitro-Mannich/lactamisation cascades for the direct synthesis of heavily decorated 5-nitropiperidin-2-ones and related heterocycles. by Jakubec, P, Cockfield, D, Helliwell, M, Raftery, J, Dixon, D

OUTCOMES AFTER TOTAL HIP REPLACEMENT by Pinedo-Villanueva, R, Turner, D, Raftery, J, Cooper, C, Arden, N

Mapping the Oxford hip score onto the EQ-5D utility index. by Pinedo-Villanueva, R, Turner, D, Judge, A, Raftery, J, Arden, N

Bis(acetylacetonato-kappa 2 O,O')[copper(II)nickel(II)(0.31/0.69)]: a mixed-metal complex by Shahid, M., Hamid, M., Mazhar, M., Malik, M.A., Raftery, J.

Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis. by Song, F, Raftery, J, Aveyard, P, Hyde, C, Barton, P, Woolacott, N

Cost-effectiveness of pharmacological interventions for smoking cessation: A literature review and a decision analytic analysis by Song, F, Raftery, J, Aveyard, P, Hyde, C, Barton, P, Woolacott, N

PRIMARY CARE COSTS ATTRIBUTABLE TO OSTEOARTHRITIS BEFORE TOTAL HIP REPLACEMENT by Pinedo-Villanueva, R, Turner, D, Raftery, J, Cooper, C, Arden, N, Grp, C

Patient self-management of anticoagulation therapy: a trial-based cost-effectiveness analysis. by Jowett, S, Bryan, S, Murray, E, McCahon, D, Raftery, J, Hobbs, F, Fitzmaurice, D

SMART: Self-Management of Anticoagulation, a Randomised Trial [ISRCTN19313375] by McCahon, D, Fitzmaurice, D, Murray, E, Fuller, C, Hobbs, R, Allan, T, Raftery, J

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease. by Clark, W, Raftery, J, Song, F, Barton, P, Cummins, C, Fry-Smith, A, Burls, A